Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.84B | 1.95B | 1.94B | 1.76B | 1.42B |
Gross Profit | 686.03M | 705.64M | 612.65M | 594.64M | 513.44M |
EBITDA | 194.71M | 290.11M | 239.42M | 253.22M | 138.74M |
Net Income | 116.64M | 112.75M | -17.81M | 121.37M | 39.66M |
Balance Sheet | |||||
Total Assets | 2.61B | 2.71B | 2.82B | 2.96B | 2.89B |
Cash, Cash Equivalents and Short-Term Investments | 188.88M | 194.53M | 180.96M | 165.18M | 181.83M |
Total Debt | 737.82M | 788.97M | 979.77M | 919.68M | 915.11M |
Total Liabilities | 1.26B | 1.33B | 1.54B | 1.57B | 1.57B |
Stockholders Equity | 1.35B | 1.38B | 1.28B | 1.39B | 1.32B |
Cash Flow | |||||
Free Cash Flow | 215.86M | 240.22M | 13.26M | 27.48M | 160.49M |
Operating Cash Flow | 204.58M | 279.02M | 41.79M | 48.93M | 178.39M |
Investing Cash Flow | -76.42M | -27.62M | -40.19M | -49.13M | -71.39M |
Financing Cash Flow | -122.66M | -238.61M | 24.67M | -13.46M | -75.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $2.02B | 21.71 | 6.78% | 1.69% | -5.72% | -19.82% | |
70 Neutral | $2.05B | 77.50 | 2.21% | 2.04% | -7.91% | -81.73% | |
69 Neutral | $2.41B | 20.42 | 11.76% | ― | 70.16% | ― | |
67 Neutral | $1.82B | 1,280.84 | 0.13% | 0.74% | -3.93% | -97.39% | |
59 Neutral | HK$16.83B | 4.60 | -5.52% | 4.39% | -3.57% | -61.41% | |
57 Neutral | $3.29B | ― | -28.05% | 2.00% | -4.31% | -1421.83% | |
50 Neutral | $1.79B | 58.21 | 4.66% | 6.99% | -0.68% | ― |
On July 18, 2025, Jeffrey Kutz resigned as Vice President, Chief Accounting Officer of Quaker Chemical Corporation, with his departure being voluntary and unrelated to any disagreement with the company. Following his resignation, Steve Dassing, who has been with the company since 2022, will assume the role of Principal Accounting Officer while maintaining his position as Vice President, Corporate Controller. The company has updated Mr. Dassing’s salary to $300,000 per annum, and he will continue to participate in the company’s incentive plans. This transition is expected to maintain stability in the company’s financial operations.
The most recent analyst rating on (KWR) stock is a Buy with a $190.00 price target. To see the full list of analyst forecasts on Quaker Chemical stock, see the KWR Stock Forecast page.
On May 14, 2025, Quaker Chemical Corporation announced the retirement of Mr. Ramaswami Seshasayee from its Board of Directors, where he served since 2019. His departure was voluntary and not due to any disagreements with the company. Following his retirement, the board’s size will be reduced from twelve to eleven members.
The most recent analyst rating on (KWR) stock is a Buy with a $190.00 price target. To see the full list of analyst forecasts on Quaker Chemical stock, see the KWR Stock Forecast page.
On March 4, 2025, Quaker Chemical held its Annual Meeting where shareholders voted on several key proposals. Four directors were elected to serve until 2028, the compensation of named executive officers was approved, and PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for fiscal year 2025.